АNALYSIS OF THE ROLE OF FOLATE CYCLE GENES IN THE PATHOGENESIS OF ROSACEA
Agzamkhodzhaeva S.S. , Tashkent State Dental Institute, Uzbekistan Azizov B.S. , Tashkent State Dental Institute, Uzbekistan Ayupova Sh.T. , Tashkent State Dental Institute, Uzbekistan Dyo K.G. , Institute Of Immunology And Human Genomics Under The Academy Of Sciences Of The Republic Of Uzbekistan Khegay T.R. , Institute Of Immunology And Human Genomics Under The Academy Of Sciences Of The Republic Of UzbekistanAbstract
The polymorphism of the genes of the folate cycle was studied. The study identified genes that are presumably involved in the occurrence and development of rosacea, as well as affecting the severity of the disease. Unfavorable variants of the folate metabolism genes: MTHFR: 1298 A>C rs1801131, MTHFR: 677C>T rs1801133. An increase in the level of homocysteine in the blood of patients with rosacea turned out to be significant. The identified loci provide specificity of inflammatory mechanisms in rosacea, and identify potential pathways for therapeutic intervention.
Keywords
Rosacea, SNP, folate
References
Daniela Rodrigues-Braz, Min Zhao, Nilufer Yesilirmak, Selim Aractingi, Francine Behar-Cohen, Jean Louis Bourges
2.Shimanskaya I.G., Kruk N.I., Khartonik A.A., Nekrashevich E.A. Belarusian Medical Academy of Post-Graduate Education, Minsk “The possibility of using folic acid drugs in dermatological practice” Meditsinskie novosti. - 2019. - N3. - P. 36-39.
Kristen Delans, Katherine Kelly & Steven R. Feldman Expert Review of Clinical Immunology.
4.Rainer BM, Kang S, Chien AL. Rosacea: epidemiology, pathogenesis, and treatment. Dermatoendocrinol. 2017; 4;9(1):e1361574.
5.Intrafamilial Transmission of Rosacea Spanning Six Generations: A Retrospective Observational Study
Wenqin Xiaoa, Ji Lia, Xin Huange, Quan Zhuf, Tangxiele Liua, Hongfu Xiea, Zhili Denga and Yan Tanga. "Mediation roles of neutrophils and high-density lipoprotein (HDL) on the relationship between HLA-DQB1 and rosacea" ANNALS OF MEDICINE 2022, VOL. 54, NO. 1, 1530–1537
7.Joerg Buddenkotte, Martin Steinhoff1 “Recent advances in understanding and managing rosacea [version 1; peer review: 3 approved]”, F1000Research 2018, 7(F1000 Faculty Rev):1885 Last updated: 03 DEC 2018
Zhili Deng, Fangfen Liu1, Mengting Chen, Chuchu Huang, Wenqin Xiao, Sini Gao, Dan Jian, Yuyan Ouyang, San Xu, Jinmao Li, Qian Shi, Hongfu Xie, Guohong Zhang, and Ji Li, Keratinocyte-Immune Cell Crosstalk in a STAT1-Mediated Pathway: Novel Insights into Rosacea Pathogenesis", ORIGINAL RESEARCH article Front. Immunol., 05 July 2021 Sec. Inflammation Volume 12 - 2021 | https://doi.org/10.3389/fimmu.2021.674871
Ayupova K. R., Yusupova L. A. The current state of the problem of rosacea. // Attending Doctor. 2022; 5-6(25): 30-33. DOI: 10.51793/OS.2022.25.6.005
Demina O.M., Potekaev N.N. Modern etiopathogenetic mechanisms of rosacea development and new methods of therapy. Clinical dermatology and venereology. 2017; 16(3):13-23.
Tan J, Berg M. Rosacea: current state of epidemiology. J Am Acad Dermatol. 2013;69(6 Suppl 1):27–35. doi: 10.1016/j.jaad.2013.04.043
McMahon F, Banville N, Bergin DA, Smedman C, Paulie S, Reeves E, et al. Activation of neutrophils via IP3 pathway following exposure to Demodex-associated bacterial proteins. inflation. 2016;39(1):425–433. doi:10.1007/s10753-015-0264-4
Gomaa AHA, Yaar M, Eyada MMK, Bhawan J. Lymphangiogenesis and angiogenesis in non-phymatous rosacea. J of Cutan Pathol. 2007;34(10):748–753. doi: 10.1111/j.1600-0560.2006. 00695.x
Smith JR, Lanier VB, Braziel RM, Falkenhagen KM, White C, Rosenbaum JT. Expression of vascular endothelial growth factor and its receptors in rosacea. Br J Ophthalmol. 2007;91(2):226–229. doi:10.1136/bjo.2006.101121
Sener S, Akbas A, Kilinc F, Baran P, Aktas A. Thiol/disulfide homeostasis as a market of oxidative
Article Statistics
Copyright License
Copyright (c) 2023 The American Journal of Medical Sciences and Pharmaceutical Research

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.